Congress Wealth Management LLC / DE / - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Congress Wealth Management LLC / DE / ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,387,651
-4.4%
159,146
+4.3%
0.09%
-14.2%
Q2 2023$4,588,476
-16.4%
152,644
+0.8%
0.11%
-19.7%
Q1 2023$5,486,596
+14.8%
151,438
+13.1%
0.13%
+7.3%
Q4 2022$4,778,065
+2.6%
133,952
-2.6%
0.12%
-2.4%
Q3 2022$4,657,000
+16.1%
137,596
-0.8%
0.13%
+23.5%
Q2 2022$4,012,000
-13.1%
138,734
-2.9%
0.10%
+1.0%
Q1 2022$4,617,000
+39.1%
142,845
+25.5%
0.10%
+53.0%
Q4 2021$3,319,000113,8460.07%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders